NEWS & EVENTS

Latest news and upcoming events

Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio
01 Jul 2026

Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio

Upcoming events

  • Swiss Biotech Day 2026
    4 May - 5 May, 2026
    Zurich

    download

  • Goodwin’s European Summit: 2026 Emerging VC Leaders in Life Sciences
    20 -22 May, 2026
    Malta

    download

  • CFO Forum
    21 - 22 May, 2026
    Málaga

    download

  • BIOSPAIN
    29 September - 1 October, 2026
    Bilbao

    download
Minoryx presents topline results from Phase 2/3 “ADVANCE” study demonstrating significant clinical benefit of leriglitazone in adrenomyeloneuropathy (AMN)<
26 Jan 2021

Minoryx presents topline results from Phase 2/3 “ADVANCE” study demonstrating significant clinical benefit of leriglitazone in adrenomyeloneuropathy (AMN)

Minoryx Therapeutics today announces that a lead investigator of the Minoryx Phase 2/3 ADVANCE clinical trial will present further results of the study at the 2021 Virtual Annual Meeting of the American Neurological Association.
Inbiomotion raises an oversubscribed financing round to launch its diagnostic product in breast cancer<
21 Jan 2021

Inbiomotion raises an oversubscribed financing round to launch its diagnostic product in breast cancer

IInbiomotion SL today announced that Alta Life Sciences has led a significantly oversubscribed investment round in the company.
Splice Bio appoints Jean-Philippe Combal as Chairman of the Board of Directors<
21 Jan 2021

Splice Bio appoints Jean-Philippe Combal as Chairman of the Board of Directors

Dr. Combal is a proven senior executive and biotechnology entrepreneur with 30 years of experience.
19 Jan 2021

Hospital Vall d’Hebron Investigators Publish Early Data on Anaconda Biomed’s Mechanical Thrombectomy System for Ischemic Stroke

Initial single-center clinical study data supporting Anaconda Biomed’s Advanced Neurovascular Access™ (ANA) Catheter System for the treatment of ischemic stroke have been published
AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial<
07 Jan 2021

AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial

First patients with COVID-19 enrolled in the REVIVAL Phase III study
06 Jan 2021

CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor

CorWave raises 35 million euros to fund the next stages of its development, with the ambition to become a world-class medtech company serving heart failure patients.
Aura Biosciences Appoints David Johnson to Its Board of Directors<
05 Jan 2021

Aura Biosciences Appoints David Johnson to Its Board of Directors

Mr. Johnson is a biopharmaceutical business leader with more than 25 years of experience in drug development.
International Consortium Awarded Eurostars Grant for the Development of First-in-class Treatment of Metastatic Cancer<
16 Dec 2020

International Consortium Awarded Eurostars Grant for the Development of First-in-class Treatment of Metastatic Cancer

ONA Therapeutics will take the lead in the LIPOLOGIC program.
15 Dec 2020

Minoryx’s clinical candidate leriglitazone shows clinical benefit in a proof of concept Phase 2 study in Friedreich´s ataxia

Minoryx Therapeutics today announces topline results from the Phase 2 FRAMES clinical trial.
Splice Bio announces research funding by Cystic Fibrosis Foundation to develop novel AAV vectors<
10 Dec 2020

Splice Bio announces research funding by Cystic Fibrosis Foundation to develop novel AAV vectors

The Company will receive up to $343,000 in research funding.

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.